Thermo Fisher Wraps Phadia Deal
Thermo Fisher Scientific, the listed, Massachusetts-based life sciences company, completed its earlier-announced acquisition of Phadia, the blood testing and allergies diagnosis company previously owned by European private equity firm Cinven.
26 August 2011•4 mins read
